Search

Author/Creator Gainor, Justin

1. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (10th December 2020)

Authors:
Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (9th November 2020)

Authors:
Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A303
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 404 ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC). (10th December 2020)

Authors:
Lee, Keun-Wook; Chung, Hyun; Kim, Won Seog; Chow, Laura; Lakhani, Nehal; Messersmith, Wells; Bang, Yung-Jue; LoRusso, Patricia; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Forgie, Alison; Wan, Hong; Pons, Jaume; Randolph, Sophia; Gainor, Justin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A245
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update. (10th December 2020)

Authors:
Bauman, Julie; Burris, Howard; Clarke, Jeffrey; Patel, Manish; Cho, Daniel; Gutierrez, Martin; Julian, Ricklie; Scott, Aaron; Cohen, Pamela; Frederick, Joshua; Robert-Tissot, Celine; Zhou, Honghong; Mody, Kinjal; Keating, Karen; Meehan, Robert; Gainor, Justin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A477
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update. (9th November 2020)

Authors:
Bauman, Julie; Burris, Howard; Clarke, Jeffrey; Patel, Manish; Cho, Daniel; Gutierrez, Martin; Julian, Ricklie; Scott, Aaron; Cohen, Pamela; Frederick, Joshua; Robert-Tissot, Celine; Zhou, Honghong; Mody, Kinjal; Keating, Karen; Meehan, Robert; Gainor, Justin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A846
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Issue 10241 (20th June 2020)

Authors:
Kuderer, Nicole M; Choueiri, Toni K; Shah, Dimpy P; Shyr, Yu; Rubinstein, Samuel M; Rivera, Donna R; Shete, Sanjay; Hsu, Chih-Yuan; Desai, Aakash; de Lima Lopes, Gilberto; Grivas, Petros; Painter, Corrie A; Peters, Solange; Thompson, Michael A; Bakouny, Ziad; Batist, Gerald; Bekaii-Saab, Tanios; ...
Journal:
Lancet
Issue:
Volume 395:Issue 10241(2020)
Page Start:
1907
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer. Issue 1 (27th January 2022)

Authors:
Blumenschein, George R; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin J; Heymach, John V; Govindan, Ramaswamy; Bachier, Carlos; Doger de Spéville, Bernard; Frigault, Matthew J; Olszanski, Anthony J; Lam, Vincent K; Hyland, Natalie; Navenot, Jean-Marc; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Prognostic Impact of KRAS Mutation Subtypes in 677 Patients with Metastatic Lung Adenocarcinomas. Issue 3 (March 2015)

Authors:
Yu, Helena A.; Sima, Camelia S.; Shen, Ronglai; Kass, Samantha; Gainor, Justin; Shaw, Alice; Hames, Megan; Iams, Wade; Aston, Jonathan; Lovly, Christine M.; Horn, Leora; Lydon, Christine; Oxnard, Geoffrey R.; Kris, Mark G.; Ladanyi, Marc; Riely, Gregory J.
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 3(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer. Issue 6 (1st June 2022)

Authors:
Lopez de Rodas, Miguel; Nagineni, Venkata; Ravi, Arvind; Datar, Ila J; Mino-Kenudson, Mari; Corredor, German; Barrera, Cristian; Behlman, Lindsey; Rimm, David L; Herbst, Roy S; Madabhushi, Anant; Riess, Jonathan W; Velcheti, Vamsidhar; Hellmann, Matthew D; Gainor, Justin; Schalper, Kurt A
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗